Abbott launches new initiative to drive diversity in medical research and improve care among under-represented populations
Abbott (NYSE: ABT) today announced the launch of a new initiative designed to help create a more inclusive clinical trial ecosystem through new approaches to training, education, and improving the clinical research
November 4, 2021
by WorldPharmaNews
Mentice receives order of total SEK 7.0 million from ABBOTT
Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, has through its fully owned subsidiary Mentice Inc entered into an agreement with ABBOTT Inc.
October 18, 2021
by prnasia
Abbott launches Panbio COVID-19 Antigen Self-Test in India
The self-test features a minimally invasive nasal swab and delivers results in as early as15 minutes with no instrumentation.
July 14, 2021
by expresspharma
Generic Pharmasec signs distribution and marketing pact with Abbott Point of Care
The company has entered into an agreement with Abbott Point of Care (APOC), the medical and diagnostics devices division of Abbott, for the distribution, marketing and promotion of the entire range of products by APOC in the entire country of India.
June 1, 2021
by expresspharma
Abbott’s AI-powered coronary imaging platform deployed in the UK
Abbott UK’s artificial intelligence- (AI) powered coronary imaging platform has been offered to the first heart attack patients in the country at the Royal Free Hospital in London.
May 14, 2021
by pharmatimes
Abbott's Fast, Reliable and Convenient COVID-19 Tests Help the Philippines Fight Infection Surge
Efforts to ramp up COVID-19 testing capacity in the Philippines have received fresh impetus, with the Office of the Civil Defense (OCD) procuring and distributing the Abbott Panbio™ COVID-19 Ag Rapid Test Device for the detection of the SARS-CoV-2 ...
April 20, 2021
by prnasia
Abbott forms Pandemic Defense Coalition
Abbott announced the formation of the Abbott Pandemic Defense Coalition, a global scientific and public health partnership for early detection of, and rapid response to, future pandemic threats.
March 15, 2021
by expresspharma
Abbott introduces NeuroSphere™ Virtual Clinic, first-of-its-kind remote neuromodulation patient-care technology in the U.S.
Abbott announced the U.S. launch of NeuroSphere™ Virtual Clinic, a first-of-its-kind technology that allows patients to communicate with physicians, ensure proper settings and functionality, and receive new treatment settings remotely as needed.
March 12, 2021
by worldpharmanews
Abbott Receives EUA for PCR Assay That Detects, Differentiates SARS-CoV-2, Flu, RSV in One Test
Abbott announced U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the company's Alinity™ m Resp-4-Plex molecular assay to detect and differentiate SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) ...
March 11, 2021
by americanpharmaceuticalreview
Abbott researchers find rare group of people with controlled HIV who could be a key to unlocking cure
Abbott announced today that a team of scientists has found an unusually high number of people in the Democratic Republic of Congo (DRC) who test positive for HIV antibodies, but have low to non-detectable viral load counts - without the use of ...
March 4, 2021
by worldpharmanews
Abbott Receives FDA 510(k) Clearance for Rapid Handheld Blood Test for Concussions
Abbott has received 510(k) clearance for the first rapid handheld traumatic brain injury (TBI) blood test, which will help clinicians assess individuals with suspected mild TBIs, including concussions.
January 15, 2021
by americanpharmaceuticalreview
Abbott receives CE mark for COVID-19 IgG quantitative antibody blood test
The new quantitative SARS-CoV-2 IgG lab-based serology test developed by Abbott has been given the CE mark.
December 17, 2020
by europeanpharmaceuticalreview